Due to the development of GHD associated with the malignancy and/or severe effects of its treatment, including chemotherapy, surgery, radiation, and biological therapy (antigen–specific monoclonal antibodies and cytotoxic T-cells), certain cancer survivors may need to be treated with GH. Here, GH1 is linked to cancer.